NIGMS 50th Anniversary Sessions at Scientific Society Meetings

NIGMS 50th Anniversary Logo

As we told you in an earlier post, NIGMS turns 50 this year. One of the ways we’re marking this milestone is by sponsoring speakers or symposia at a number of scientific society meetings.

We’ve already been to the Society for Glycobiology and the American Society for Cell Biology meetings, and in the coming months, we’re headed to these additional venues:

  • Biophysical Society
  • United Mitochondrial Disease Foundation
  • Genetics Society of America
  • International Society for Computational Biology
  • American Chemical Society
  • Society for Advancement of Chicanos and Native Americans in Science
  • Annual Biomedical Research Conference for Minority Students

If you’ll be at one of these meetings, please come to our sponsored session to hear from our grantees and meet some of our staff. Also, please acknowledge NIGMS funding support during your meeting talks and poster presentations, and feel free to use one of our 50th anniversary logos for this purpose.

To highlight our commitment to training, we’re also sponsoring student or postdoctoral fellow poster awards at a number of these events. We’ll invite poster award winners to present their work at the NIGMS 50th anniversary symposium at NIH on October 17. Stay tuned for details about that event in a future post.

Remarkable Ruth Kirschstein: New Biography of an NIGMS Director

As the director of NIGMS from 1974 to 1993, Ruth L. Kirschstein molded the Institute’s agenda for basic science, research training and promoting diversity. She also set a tone for the Institute that remains to this day. After leaving NIGMS, Ruth went on to serve as the deputy director of NIH, and, for two periods, she was NIH’s acting director.

From the time she recruited me to NIGMS in 1981 until her death in 2009, Ruth was also my mentor and friend, as she was to many others who worked for or interacted with her.

A new biography by science writer Alison Davis, Always There: The Remarkable Life of Ruth Lillian Kirschstein, M.D., tells the inspiring story of a scientist, physician, administrator, leader, humanitarian, classical pianist, lover of music and art, and devoted wife and mother. This amazing, multitasking woman really was “always there.”

I highly recommend this book to anyone interested in reading about an extraordinary woman and her dedication and many contributions to NIH and beyond. The book is available for free in several digital formats.

NIGMS Reorganizes

In the first major reorganization of NIGMS since 1994, we have just established two new divisions that bring together existing NIGMS programs with programs transferred to NIGMS from the former National Center for Research Resources (NCRR). These changes give us the opportunity to create synergies and strengthen efforts in areas that are central to our mission.

The Division of Training, Workforce Development, and Diversity (TWD) merges NIGMS research training programs with activities that were previously in the Institute’s Division of Minority Opportunities in Research (MORE). It also houses the Institutional Development Award program from NCRR. Our decision to create this division was informed by input we received from many stakeholders, and it responds to key goals and recommendations of our strategic plans. Its director is Clif Poodry, who formerly directed the MORE Division.

The Division of Biomedical Technology, Bioinformatics, and Computational Biology (BBCB) combines programs of our Center for Bioinformatics and Computational Biology (CBCB) with biomedical technology programs from NCRR. Karin Remington, who previously directed CBCB, is the director of this new division.

You might be wondering what the reorganization will mean for your current or future funding. The amount of money allocated to programs in the new divisions will not change as a result of the reorganization or the transfer of NCRR programs to NIGMS. The review of applications will stay the same, too, as will most of the staff who manage the grants and review the applications.

Our current organizational chart shows all six NIGMS divisions, including the two new ones.

I’ve been at NIGMS for many years—first as a program director, then as a division director and twice as acting Institute director. One of the things I like best about all these jobs is having a bird’s-eye view of the rapid evolution of science. The reorganization that is taking place at NIGMS reflects this evolution and, I expect, will enable NIGMS to further enhance the pace of science.

Marking Our Golden Anniversary

NIGMS 50th Anniversary Logo

NIGMS turns 50 in 2012! To mark this important milestone, we’re planning a variety of activities throughout the year, including sessions at scientific society meetings and a symposium on the NIH campus on October 17, 2012. We’re also planning a special page on the NIGMS Web site where you can share your perspectives on the Institute and its role.

We invite you to describe how NIGMS has had an impact on your research or institution, or how it has made a difference in your field. We also welcome your memories or reflections on other relevant topics. The length and format (text, audio, video, image) are up to you. Text can be entered on the NIGMS 50th Anniversary Personal Reflections page (no longer available) or you may send text or other materials to

We’ll compile the submissions and post an assortment of them on our Web site in early 2012. While there is no specific deadline, we’d like to receive as many contributions as possible by the end of 2011.

Finally, as a way of sharing our anniversary with the broader scientific community, you may wish to use our 50th anniversary logo (link no longer available) during 2012 on posters and other materials about NIGMS-funded research.

Chris A. Kaiser Selected as NIGMS Director

Photo of Chris Kaiser, Ph.D.NIH Director Francis Collins today announced his selection of Chris A. Kaiser as the new director of NIGMS. Dr. Kaiser expects to begin his appointment here in the spring of 2012. We are delighted by this news, and we appreciate the efforts of the NIH search committee in identifying and vetting candidates for the position.

A leading cell biologist, Dr. Kaiser has been head of the Department of Biology at MIT since 2004. He joined the MIT faculty in 1991 and became a full professor in 2002.

Dr. Kaiser is not new to the NIGMS community—he has been an NIGMS grantee since 1992 and has served on several NIH review committees. His research uses yeast to study the basic mechanisms of protein folding and intracellular transport, particularly how secreted and other proteins form disulfide bonds. He started this work as a graduate student at MIT in David Botstein’s lab, then expanded on it during a postdoctoral fellowship with Randy Schekman at the University of California, Berkeley. He plans to continue his research at NIH.

In the NIH news release on his selection, Dr. Kaiser said, “In taking this position, I feel a compelling call to duty for national service and to be an advocate for the basic research enterprise.”

We welcome his leadership and vision, and we very much look forward to working with him.

Nobel Prize and Other Honors

Bruce BeutlerWe are pleased that Bruce Beutler, who has been an NIGMS grantee since 2000, is a recipient of this year’s Nobel Prize in physiology or medicine Exit icon. He was cited for “discoveries concerning the activation of innate immunity.” We congratulate him on this great honor.

Beutler has been at the Scripps Research Institute since 2000 but is moving back to the University of Texas Southwestern Medical Center, which is where he worked when he discovered the receptor for endotoxin in 1998.

While we did not support him at that time, we began funding him shortly thereafter to further explore this seminal discovery. Our first grant to him was titled “TLR4 as an LPS Sensor and Susceptibility Locus,” and our second was titled “Mutagenic Analysis of LPS Responses.” The latter grant, which is still active, was awarded as an R01 in 2003 and converted to an R37 (MERIT Award) in 2008.

With this support, Beutler pioneered the use of a novel mutagenesis process in model systems to characterize several key intermediates in the Toll-like receptor signaling pathway of the innate immune response. These and other advances have formed a molecular framework for a deeper understanding of innate immunity, which is essential for normal host defense but which can also go awry, causing chronic inflammatory diseases and sepsis.

Today’s Nobel news comes on the heels of last week’s announcement that the National Medal of Science Exit icon will go to two of our grantees, Jackie Barton of Caltech and Peter Stang of the University of Utah.

And at the other end of the career spectrum, NIGMS grantee Sara Sawyer of the University of Texas at Austin is among the 20 NIH-funded scientists who were just selected for the Presidential Early Career Award for Scientists and Engineers. This award is the nation’s highest honor for scientists at the beginning of their professional careers.

We congratulate these grantees on their notable recognitions.

Lasker Award Highlights Protein Folding Discoveries

Crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex (PDB ID: 1aon).The Lasker Awards recognize major contributions to understanding and treating, curing or preventing disease. The 2011 prizes were announced yesterday, and we’re proud that two former NIGMS grantees, Franz-Ulrich Hartl of the Max Planck Institute of Biochemistry and Arthur L. Horwich of the Yale School of Medicine, are being honored with the Basic Medical Research Award Exit icon.

Hartl and Horwich are cited for their discoveries about the cell’s protein-folding machinery, particularly the identification of chaperonin, which shifted the paradigm of how proteins fold. The field of protein folding is a great example of the importance of the basic research that NIGMS funds and how it lays the foundation for medical advances—in this case, shedding light on diseases linked to misfolding or aggregation, such as Alzheimer’s and amyotrophic lateral sclerosis.

We’re also delighted that the NIH Clinical Center was selected to receive the Lasker-Bloomberg Public Service Award Exit icon.

We congratulate all of the recipients on these well-deserved honors.

Revised Financial Conflicts of Interest Regulations

The revised regulations Exit icon on extramural investigators’ financial conflicts of interest have been published in the Federal Register. The final rule is based on input NIH received from the community.

The revised regulations, as outlined by NIH’s Sally Rockey, now:

  • Require investigators to disclose to their institutions all of their significant financial interests related to their institutional responsibilities as opposed to only those that they see as related to Public Health Service (PHS)-supported research.
  • Lower the monetary threshold for disclosure of significant financial interests, from $10,000 to $5,000.
  • Require institutions to report to the PHS awarding component more comprehensively on identified financial conflicts of interest and how they are being managed.
  • Require institutions to make certain information concerning identified financial conflicts of interest held by senior/key personnel accessible to the public.
  • Require investigators to be trained on the regulations and their institution’s financial conflict of interest policy at designated times.

NIH is developing training materials, which will be posted on its Financial Conflict of Interest Web site. For more details, visit the “quick links.”

Forging Ahead

Under Jeremy Berg’s leadership, NIGMS has thrived and continued to support outstanding, cutting-edge research. I hope to maintain this momentum while serving as acting NIGMS director.

Many of you know me from the Division of Genetics and Developmental Biology, the part of NIGMS I’ve directed since 1988. Others know me from the NIH Director’s Pioneer and New Innovator Award programs, which I’ve led for a number of years, or from my role in chairing NIGMS’ strategic planning processes. Some may even recall when I previously served as acting NIGMS director (from May 2002, when Marvin Cassman left, to November 2003, when Jeremy arrived).

In this time of transition, we are managing a challenging budget situation and also pursuing several major activities. One is implementing action items from the training strategic plan. I am excited to see this effort come to fruition, as it will have a significant impact on both students in our training programs and those supported by regular research grants.

In addition, we are looking forward to marking the Institute’s 50th anniversary in 2012. Planning is already under way for activities at scientific meetings and on the NIH campus. We will post more details here in the coming months.

And of course we eagerly anticipate the selection of a new NIGMS director. The search committee is a terrific group of people who know the Institute well. I have a lot of confidence that they will find us a director who will continue NIGMS’ strong tradition of excellent leadership.

Part of Jeremy’s legacy at NIGMS is the Feedback Loop. Keeping open lines of communication has always been really important to us, and I welcome your input at any time.


Today is my last day as Director of NIGMS. It is hard to believe that almost 8 years have passed since I was first offered this tremendous opportunity to serve the scientific community. It has been a privilege to work with the outstanding staff members at NIGMS and NIH, as well as with so many of you across the country.

As I write my final post, I find myself recalling a statement I heard from then-NIH Director Elias Zerhouni during my first few years here: It is very difficult to translate that which you do not understand. He made this comment in the context of discussions about the balance between basic and applied research, which certainly has applicability in this setting and is relevant in a broader context as well. In some ways, it has also been my mantra for the NIGMS Feedback Loop.

Early in my time at NIH, I was struck by how often even relatively well-informed members of the scientific community did not understand the underlying bases for NIH policies and trends. Information voids were often filled with rumors that were sometimes very far removed from reality. The desire to provide useful information to the scientific community motivated me and others at NIGMS to start the Feedback Loop, first as an electronic newsletter and, for the past 2 years, as a blog. Our goal was–and is–to provide information and data that members of the scientific community can use to take maximal advantage of the opportunities provided across NIH and to understand the rationales behind long-standing and more recent NIH policies and initiatives.

I chose the name Feedback Loop with the hope that this venue would provide more than just a vehicle for pushing out information. I wanted it to promote two-way communication, with members of the scientific community feeling comfortable sharing their thoughts about the material presented or about other issues of interest to them. In biology, feedback loops serve as important regulatory mechanisms that allow systems to adjust to changes in their environments. I hoped that NIGMS’ “feedback loop” would serve a similar role.

I am pleased with our progress toward this goal, but there is considerable room for further evolution. The emergence and success of similar blogs such as Rock Talk are encouraging signs. I know that NIGMS Acting Director Judith Greenberg shares my enthusiasm for communication with the community, and I hope that the new NIGMS Director will too. I encourage you to continue to play your part, participate in the discussions and engage in the sort of dialogue that will best serve the scientific community.

I plan to continue communicating with many of you in my new position as a member of the extramural scientific community. For the time being, you can reach me at